Loss-of-function mutations in NF1 lead to intracellular neurofibromin protein deficiency, followed by over-activation of RAS signaling to the downstream pathways, which consequently leads to the development of phenotypes characterized by pigmentary lesions and predispositions to neoplastic disorders (3). Here, NF1 is linked to neoplastic disease or syndrome.